GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NanoVibronix Inc (NAS:NAOV) » Definitions » Shiller PE Ratio

NanoVibronix (NanoVibronix) Shiller PE Ratio : (As of Jun. 10, 2024)


View and export this data going back to 2015. Start your Free Trial

What is NanoVibronix Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


NanoVibronix Shiller PE Ratio Historical Data

The historical data trend for NanoVibronix's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoVibronix Shiller PE Ratio Chart

NanoVibronix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NanoVibronix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NanoVibronix's Shiller PE Ratio

For the Medical Devices subindustry, NanoVibronix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NanoVibronix's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NanoVibronix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where NanoVibronix's Shiller PE Ratio falls into.



NanoVibronix Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

NanoVibronix's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, NanoVibronix's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.23/131.7762*131.7762
=-0.230

Current CPI (Mar. 2024) = 131.7762.

NanoVibronix Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -4.427 100.560 -5.801
201409 -5.867 100.428 -7.698
201412 -6.127 99.070 -8.150
201503 -4.825 99.621 -6.382
201506 -2.000 100.684 -2.618
201509 -4.600 100.392 -6.038
201512 -3.200 99.792 -4.226
201603 -2.200 100.470 -2.886
201606 -2.600 101.688 -3.369
201609 -2.600 101.861 -3.364
201612 -5.000 101.863 -6.468
201703 -7.400 102.862 -9.480
201706 -3.600 103.349 -4.590
201709 -7.000 104.136 -8.858
201712 -5.200 104.011 -6.588
201803 -2.400 105.290 -3.004
201806 -2.600 106.317 -3.223
201809 -4.200 106.507 -5.196
201812 -3.600 105.998 -4.476
201903 -8.000 107.251 -9.829
201906 -3.200 108.070 -3.902
201909 -2.400 108.329 -2.919
201912 -3.400 108.420 -4.132
202003 -2.600 108.902 -3.146
202006 -4.000 108.767 -4.846
202009 -2.000 109.815 -2.400
202012 -0.947 109.897 -1.136
202103 -4.000 111.754 -4.717
202106 -0.200 114.631 -0.230
202109 -5.200 115.734 -5.921
202112 -1.950 117.630 -2.185
202203 -0.810 121.301 -0.880
202206 -0.930 125.017 -0.980
202209 -0.680 125.227 -0.716
202212 -1.420 125.222 -1.494
202303 -0.670 127.348 -0.693
202306 -0.650 128.729 -0.665
202309 -0.420 129.860 -0.426
202312 -0.390 129.419 -0.397
202403 -0.230 131.776 -0.230

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NanoVibronix  (NAS:NAOV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


NanoVibronix Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of NanoVibronix's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoVibronix (NanoVibronix) Business Description

Traded in Other Exchanges
Address
525 Executive Boulevard, Elmsford, New York, NY, USA, 10523
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
Executives
Christopher M Fashek director 8023 VANTAGE DR, SAN ANTONIO TX 78230
Stephen Russell Brown officer: Chief Financial Officer 18-B NEIL COURT, OCEANSIDE NY 11572
Aurora Cassirer director C/O NANOVIBRONIX, INC.,, 525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
Maria Schroeder director C/O NANOVIBRONIX, INC.,, 525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
Brian M Murphy director, officer: Chief Executive Officer 525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
Michael Ferguson director 525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
Thomas Mika director TEGAL CORP, 2201 SOUTH MCDOWELL BLVD, PETALUMA CA 94954
Ira A Greenstein director IDT CORP, 520 BROAD STREET, NEWARK NJ 07102
Harold Jacob director, officer: Chief Medical Officer HAADMUR MEBUYON 26, HARNOT, JERUSALEM L3 95403
Martin M Goldstein director C/O NANOVIBRONIX, INC., 525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
William Stern director, officer: Chief Executive Officer 525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
Jona Zumeris director, officer: VP of Technology 105 MAXESS ROAD, SUITE S124, MELVILLE NY 11747
Miriam W Kelly 10 percent owner P.O. BOX 1443, BROOKLANDVILLE MD 21022